Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Medulloblastoma × Cytarabine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Leukemia, Myeloid, Acute 494 Leukemia 250 Precursor Cell Lymphoblastic Leukemia-Lymphoma 199 Lymphoma 134 Myelodysplastic Syndromes 95 Leukemia, Monocytic, Acute 77 Burkitt Lymphoma 77 Congenital Abnormalities 76 Lymphoma, Non-Hodgkin 75 Leukemia, Myelomonocytic, Acute 74 Leukemia, Erythroblastic, Acute 69 Lymphoma, Large B-Cell, Diffuse 66 Leukemia, Megakaryoblastic, Acute 66 Recurrence 59 Lymphoma, Mantle-Cell 59 Lymphoma, Follicular 42 Hodgkin Disease 40 Leukemia, Myelomonocytic, Chronic 39 Leukemia, Biphenotypic, Acute 37 Lymphoma, Large-Cell, Immunoblastic 34 Anemia, Refractory, with Excess of Blasts 30 Myeloproliferative Disorders 29 Leukemia, Lymphocytic, Chronic, B-Cell 29 Blast Crisis 29 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 27 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 24 Lymphoma, B-Cell, Marginal Zone 21 Leukemia, Myeloid, Chronic-Phase 21 Leukemia, Eosinophilic, Acute 21 Multiple Myeloma 20

Interventions

Cyclophosphamide 29 Temozolomide 28 Filgrastim 24 Etoposide 22 Carboplatin 22 Vincristine 18 Cisplatin 18 Radiotherapy 17 Magnetic Resonance Spectroscopy 15 Thiotepa 13 Irinotecan 11 Granulocyte Colony-Stimulating Factor 11 Peripheral Blood Stem Cell Transplantation 10 Melphalan 9 Lomustine 9 Specimen Handling 8 Methotrexate 8 Radiation 7 etoposide phosphate 6 X-Rays 6 Topotecan 6 Phantoms, Imaging 6 Biopsy 6 Platinum 5 Nuclear Medicine Department, Hospital 5 Busulfan 5 Bevacizumab 5 1,2-diaminocyclohexaneplatinum II citrate 5 sonidegib 4 sargramostim 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01356290 2026-02-23

MEMMAT

Medical University of Vienna

Phase 2 Recruiting

Ependymoma, Medulloblastoma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡